Trial
NCT05497284
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
LTP001
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-13